Clinical trial

A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following…

NCT00187330 · Sunnybrook Health Sciences Centre, Other · Completed

Key facts

NCT number NCT00187330
Title A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass
Official title A Randomized Placebo Controlled Trial of Intravenous N-Acetylcysteine (NAC) As A Renal Protective Agent for Prevention of Renal Dysfunction Following Cardiopulmonary Bypass (CPB)
Lead sponsor Sunnybrook Health Sciences Centre, Other
Collaborators The Physicians' Services Incorporated Foundation
Status Completed
Phase Phase 2
Study type Interventional
Conditions Heart Disease, Renal Insufficiency
Intervention type Drug
Interventions Intravenous N-acetylcysteine
Enrollment 104
Start date Mar 1, 2004
Completion Aug 1, 2005
First posted Sep 16, 2005
Last update posted Sep 16, 2005

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies